标题：Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C
摘要：During chronic hepatitis C virus (HCV) infection, both CD4 and CD8 T-cells become functionally exhausted, which is reflected by increased expression of programmed cell death-1 (PD-1) and T-cell immunoglobulin and mucin domain-containing protein 3 (Tim-3), and elevated anti-inflammatory interleukin 10 (IL-10) plasma levels. We studied 76 DAA-treated HCV-positive patients and 18 non-infected controls. Flow cytometry measured pretreatment frequencies of CD4 PD-1 , CD4 PD-1 Tim-3 and CD8 PD-1 Tim-3 T-cells and IL-10 levels measured by ELISA were significantly higher and CD4 PD-1−Tim-3− and CD8 PD-1−Tim-3− T-cells were significantly lower in patients than in controls. Treatment resulted in significant decrease of CD4 Tim-3 , CD8 Tim-3 , CD4 PD-1 Tim-3 and CD8 PD-1 Tim-3 T-cell frequencies as well as IL-10 levels and increase in CD4 PD-1−Tim-3− and CD8 PD-1−Tim-3− T-cells. There were no significant changes in the frequencies of CD4 PD-1 T-cells, while CD8 PD-1 T-cells increased. Patients with advanced liver fibrosis had higher PD-1 and lower Tim-3 expression on CD4 T-cells and treatment had little or no effect on the exhaustion markers. HCV-specific CD8 T-cells frequency has declined significantly after treatment, but their PD-1 and Tim-3 expression did not change. Successful treatment of chronic hepatitis C with DAA is associated with reversal of immune exhaustion phenotype, but this effect is absent in patients with advanced liver fibrosis.
其他摘要：Abstract During chronic hepatitis C virus (HCV) infection, both CD4 and CD8 T-cells become functionally exhausted, which is reflected by increased expression of programmed cell death-1 (PD-1) and T-cell immunoglobulin and mucin domain-containing protein 3 (Tim-3), and elevated anti-inflammatory interleukin 10 (IL-10) plasma levels. We studied 76 DAA-treated HCV-positive patients and 18 non-infected controls. Flow cytometry measured pretreatment frequencies of CD4 PD-1 , CD4 PD-1 Tim-3 and CD8 PD-1 Tim-3 T-cells and IL-10 levels measured by ELISA were significantly higher and CD4 PD-1 − Tim-3 − and CD8 PD-1 − Tim-3 − T-cells were significantly lower in patients than in controls. Treatment resulted in significant decrease of CD4 Tim-3 , CD8 Tim-3 , CD4 PD-1 Tim-3 and CD8 PD-1 Tim-3 T-cell frequencies as well as IL-10 levels and increase in CD4 PD-1 − Tim-3 − and CD8 PD-1 − Tim-3 − T-cells. There were no significant changes in the frequencies of CD4 PD-1 T-cells, while CD8 PD-1 T-cells increased. Patients with advanced liver fibrosis had higher PD-1 and lower Tim-3 expression on CD4 T-cells and treatment had little or no effect on the exhaustion markers. HCV-specific CD8 T-cells frequency has declined significantly after treatment, but their PD-1 and Tim-3 expression did not change. Successful treatment of chronic hepatitis C with DAA is associated with reversal of immune exhaustion phenotype, but this effect is absent in patients with advanced liver fibrosis.
